TerrAscend Earnings + Call Notes
U.S. canna leader talks through Q323.
$89.6M Revs; est. $82.8M
$24.2M AEBITDA; est. $16.5M
$47.8M GP; est. $41.2M
$53.6% GM; est. 49.7%
(.04) EPS; est. (0.01)
*Sees FY AEBITDA $73M vs. $63M
*Sees FY Revs $320M vs. $317M
FCF $7.7M
CFFO $9.4M
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.